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ABSTRACT 
Background: A growing body of evidence suggests that depression are related to dementia in 
older adults. Previous research have been done in high-income countries and it is a lack of 
studies in low- and middle income countries (LMICs). 
Objective: To examine the relation between depressive symptoms and incidence of dementia 
in a population-based study of older adults in Latin America.  
Methods: The study is a part of the 10/66 Dementia Research Group’s population survey and 
include 11472 older adults (baseline mean age 74 years) from Cuba, Dominican Republic, 
Mexico, Peru, Puerto Rico, and Venezuela. The baseline examinations were done in 2003-07 
and the follow-up examinations 4 years later. Semi-structured psychiatric interviews gave 
information about ICD-10 depression and sub-syndromal depression (i.e. ≥4 depressive 
symptoms) at baseline. Information on dementia were collected at the follow-up examination. 
Competing risk models analysed the associations between depression and incidence of 
dementia and the final model were adjusted for age, sex, education, stroke and diabetes. 
Separate analyses were conducted for each site and then meta-analysed by means of fixed effect 
models.  
Results: At baseline, the prevalence of depression was 26.0% (n=2980), 5.4% had ICD-10 
depression and 20.6% sub-syndromal depression. During the follow-up period developed 9.3% 
(n=862) dementia and 14.3% (n=1329) deceased. In the pooled analyses, both ICD-10 
depression (adjusted sub-hazard ratio (sHR) 1.63, 95% confidence interval (CI) 1.26-2.11) and 
sub-syndromal depression (adjusted sHR 1.28, 95% CI: 1.09-1.51) were associated with 
increased incidence of dementia. The Higging I2 tests showed a moderate heterogeneity across 
the study sites. 
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Conclusion: Our findings suggest that late-life depression is associated with the incidence of 
dementia in LMICs in Latin America, which support results from earlier studies conducted in 
high-income countries.   
Keywords: Dementia, Depression, Developing countries, Epidemiology, Risk factors 
 
  
Associations between depression and incidence of dementia in Latin America 
 
4 
 
Introduction 
Demographic ageing is a worldwide phenomenon and number of people with dementia are 
increasing rapidly [1].  In low- and middle income countries (LMICs), dementia cases are 
expected to more than triple by 2050 [1]. Latin America have a high prevalence of dementia 
(standardised prevalence = 8.3), compared to for example North America (5.7), Asia (5.6-7.7), 
Africa (4.6), and Europe (4.7-6.7) [2]. In addition, depression is a common condition in late-
life [3, 4] and population-based studies report that as many as one third of older adults in LMICs 
and Latin America could be affected by depressive syndromes [4, 5].  
 
A growing body of evidence suggests that late-life depression are related to onset of dementia. 
Several epidemiological studies have observed this relationship and meta-analyses have 
repeatedly reported a two-fold higher risk for dementia in people with depression [6-9]. The 
characteristics of this relationship are not yet sufficiently understood and some studies report 
contradictory results, i.e., that depression has no effect of the trajectory of dementia [10, 11]. 
Whilst progress has been made, a glaring omission in the literature shows that almost all prior 
studies on this topic have been conducted in high-income countries. According to the latest 
systematic review, only one study was carried out in a middle-income country, i.e. in China [9].  
 
The association between depression and onset of dementia can be explained in several ways. 
Depression can be a trigger for damaging neuropathological processes in the brain, e.g. through 
alterations in the nervous, vascular and inflammatory systems [12]. Episodes of severe 
depression have earlier been associated with pathological changes in specific regions in the 
brain, e.g. in the prefrontal cortex, [13] in the hippocampus area [14] and in sub-cortical white 
matter [15]. Symptoms of depression may also be a psychological reaction to a cognitive and 
functional decline, or reflect a prodromal state of dementia.  
  
Associations between depression and incidence of dementia in Latin America 
 
5 
 
Whilst existing studies on the association between depression and dementia show inconsistency 
and mainly have been carried out in high-income countries [6-9], it is not known whether this 
relation can be found in other settings. The aim of this study was to examine the association 
between depression and incidence of dementia over a 4-year follow-up period, in a large 
population-based sample of older people living in six LMICs in Latin America. 
 
Methods 
Setting and participants 
The analyses originate from the 10/66 Dementia Research Group population-based survey, 
which include persons aged ≥ 65 years living in geographically defined catchment areas in 
urban and rural sites in Latin America [1, 16]. Baseline examinations were carried out between 
2003 and 2007 (depending on site) and included clinical interviews, physical examinations and 
informant interviews, which generated information about e.g. cognitive and mental disorders, 
physical health, socio-demographic factors, disability, and use of health services. Trained 
interviewers examined the participants’ in their own homes (2-3 hours) and all instruments were 
translated, back translated and assessed for acceptance and conceptual equivalence [17]. The 
follow-up examinations were conducted 3 to 5 years after baseline and were essentially a repeat 
of the first examination. The 10/66 study has earlier been described in details [1, 16].  
 
Persons with dementia at baseline (n=1441) were removed from all analyses. Of the remaining 
11 472 persons, 7857 participated in the follow-up examination (2160 were lost to follow up 
and 1475 had deceased). Post-mortem informant interviews were done in the majority of people 
who had deceased (n=1455, 99%), using the World Health Organization's “Standard Verbal 
Autopsy Questionnaire 3: Death of a Person Aged 15 Years and Above”, as described elsewhere 
[18]. The final analyses included 9312 participants from Cuba (n=2339), Dominican Republic 
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(n=1441), Peru (n=1328), Venezuela (n=1353), Mexico (n=1521), and Puerto Rico (n=1374). 
(See flow-chart in Figure 1.) All subjects provided informed consent to participate, either by 
themselves or through their next-of-kin. The data collection and study procedure were approved 
by the local ethics committees and by the King’s College; London Research Ethics Committee.  
 
Diagnosis of depression  
Two definitions of depression were used: (I) ICD-10 depression (code F32) [19] and (II) sub-
syndromal depression (≥4 symptoms in the EURO-D scale, but not fulfilling the ICD-10 
criteria). Both ICD-10 and EURO-D items were drawn from the semi-structured Geriatric 
Mental State (GMS) interview, which assess symptoms of depression during the last month 
[20]. The GMS interview is a widely used mental-health assessment for older people. The 
EURO-D symptom scale include 12 depressive symptoms, i.e., depressed mood, pessimism, 
wishing death, guilt, sleep, interest, irritability, appetite, fatigue, concentration, enjoyment and 
tearfulness. Each item score 1 (present symptom) or 0 (no present symptom) [21]. The scale 
was originally developed to compare symptoms of late-life depression across European 
countries in the EURODEP Concerted Action Programme [22]. A computerised diagnostic 
algorithm, the AGECAT (Automated Geriatric Examination for Computer Assisted Taxonomy) 
grouped symptoms to identify diagnoses, according to e.g. the ICD-10 criteria [19, 20, 23, 24]. 
The reliability and validity of the GMS/AGECAT algorithm has been investigated in several 
previous studies [4, 25]. 
 
Diagnosis of dementia 
Dementia was defined through an algorithm authorized by the 10/66 Dementia Research Group 
[26]. The algorithm have been calibrated and validated in a large cross-cultural pilot study and 
is described in details elsewhere [17, 26]. The diagnosis of dementia was allocated to 
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individuals scoring above a cut-off point of predicted probability for dementia, calculated with 
coefficients derived from a logistic regression equation, and based on the combined information 
from: (I) the GMS interview [21, 24], (II) cognitive tests, i.e., the Community Screening 
Instrument for Dementia (CSI‘D’) [27] and a verbal fluency test [28], and (III) informant 
reports of cognitive and functional decline (from the CSI‘D’ instrument) [29]. For individuals 
who died between baseline and follow-up, a post-mortem informant interview was used to 
assess whether there was evidence of cognitive and functional decline [26]. Participants who 
were suspected to have died with dementia were coded as ‘cases of dementia’.   
 
Potential confounders 
A number of socio-demographic and health characteristics were added to the analyses. They 
were all selected on the basis that they either were assumed to have a potential confounding 
effect on the association between depression and dementia, or were used in previous studies 
researching this association. The potential confounders included age (continuous in year), 
gender (female/male), educational level (none, not completed primary, completed primary, 
completed secondary and tertiary education), stroke (“Have you ever been told by a doctor that 
you had a stroke?”; coded yes if there was a clear history of sudden onset of unilateral paralysis, 
loss of speech, or blindness lasting for more than 24 hours) [30], and diabetes (“Have you ever 
been told by a doctor you had diabetes?” coded yes/no) [30]. 
 
Statistical analyses 
First, we analysed the socio-demographic and health characteristics for each study site and for 
the total sample. Second, we calculated person-years from the date of baseline examination to 
(I) the date of death in persons deceased without dementia, (II) the date of follow-up interview 
in survivors free from dementia, or (III) the date of dementia onset (i.e., the midpoint between 
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the baseline examination and the follow-up examination or post-mortem interview). Third, we 
tested associations between ICD-10 depression and dementia, and sub-syndromal depression 
and dementia, acknowledging the possibility of a dementia-free death (competing event). The 
reference group were participants without depression. Sub-hazard ratios (sHR) were derived 
from Fine and Gray’s proportional hazard models [31]. To test the proportionality of sub-
hazards we included time interactions on all the co-variates as a way of testing the proportional 
sub-hazards assumption for each. We found that no indication that proportionality assumption 
had been violated.  
 
Competing risk models were run separately in each site and then pooled together by fixed effect 
meta-analysis, using inverse-variance weighting together with an estimation of heterogeneity 
using the Higgins I2. Higgins I2 was computed to estimate the proportion of between-site 
variability in the estimates accounted for by heterogeneity as opposed to sampling error (up to 
40% heterogeneity is conventionally considered negligible, while up to 60% reflects moderate 
heterogeneity). The 1st model was unadjusted, the 2nd model adjusted for age, gender, and 
education level, and the 3rd model adjusted for age, gender, education level, stroke, and diabetes.  
The statistical significance was defined as a p-value <.05 (two-tailed) in all analyses. 
 
Finally, three additional sensitivity analyses where conducted: (I) a competing risk regression 
model was used to repeat the analyses and categorising everyone who died as “deceased without 
dementia", i.e. not using the post-mortem informant information about dementia at time of 
death (Supplementary Table 1), (II) we repeated the analyses using Cox regression models 
instead of competing risk models (Supplementary Table 2), and finally (III) we repeated the 
meta-analyses to pool countries together by removing one country at the time, i.e. leave-one-
out validation. This was done to assess the impact that each individual site had on the pooled 
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estimates and the robustness of the findings. All data analysis was performed using Stata 13 
(StataCorp, College Station, TX, USA). 
 
Results 
The characteristics of the study participants (n=11 472, 64% women) are presented in Table 1. 
At baseline (mean age=74.0±6.7), the prevalence of ICD-10 depression was 5%, whereas 21% 
met the criteria for sub-syndromal depression. Depression and sub-syndromal depression was 
more common in women than in men (31% vs. 18%) and varied between study sites, from 16% 
in Puerto Rico to 37% in the Dominican Republic. During the 4 years of follow-up, 862 of the 
participants developed dementia, 736 were detected at the examination and 126 in the post-
mortem informant interviews. The incidence of dementia was slightly more common in women 
than in men (10% vs. 8%) and varied from 6% in Peru to 12% in Dominican Republic and 
Venezuela. One thousand fifty-five participants deceased without a diagnosis of dementia. 
 
In the pooled meta-analysis, people with ICD-10 depression had an 85% increased risk of 
developing dementia during follow-up period (sHR 1.85, 95% CI 1.44-2.37, I2 45.9%), 
compared to people without depression (Table 2). The association remained after adjusting for 
potential confounders (pooled fully adjusted sHR 1.63, 95% CI 1.26-2.11, I2 40.9%). The 
hazard estimates varied between the study sites. Cuba (sHR 2.53, 95% CI 1.58-4.07) and 
Venezuela (sHR 2.84, 95% CI 1.62-4.97) had the highest sHR, while Dominican Republic (sHR 
1.18, 95% CI 0.75-1.85) and Puerto Rico (sHR 0.76, 95% CI 0.18-3.20) had the lowest observed 
estimations. Sub-syndromal depression was associated with a 37% increased risk of developing 
dementia (95% CI 1.17-1.60, I2 53.7%) in the pooled meta-analysis (Table 3).  
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When the analyses where repeated by categorising everyone who died as ‘deceased without 
dementia’, i.e. not using the post-mortem informant information about suspected dementia at 
time of death, the risk estimation of dementia where similar both for ICD-10 depression (pooled 
fully adjusted sHR 1.51) and sub-syndromal depression (pooled fully adjusted sHR 1.33) 
(Supplementary Table 1). Also the Cox regression models showed similar estimates as the 
competing risk models, both according to ICD-10 depression (pooled fully adjusted sHR 1.74) 
and sub-syndromal depression (pooled fully adjusted sHR 1.32) (Supplementary Table 2).  
 
When repeated the meta-analyses and removing one study at the time, i.e. leave-one-out 
validation test, in Table 2, the pooled estimates did not change and their 95% CI did not overlap. 
Removing Venezuela from Model 3 resulted in a pooled estimate of sHR 1.12 (95% CI 0.93-
1.34). Removing other countries did not affect the results.  
 
Discussion 
In a large population-based sample of older adults in six defined regions in Latin America, we 
found that depression was associated with a higher incidence of dementia over a 4-year follow-
up period. The strongest associations were observed in people with ICD-10 depression but also 
in people with sub-syndromal depression (≥4 symptoms in the EURO-D, no confirmed ICD-10 
depression) had higher risk of developing dementia. The study sites differed both according to 
prevalence of depression (e.g. ICD-10 depression ranged from 13% to 25%) and according to 
the hazard estimates (adjusted sHRs ranged between 0.81 and 2.48 for ICD-10 depression.   
 
To the best of our knowledge, the present 10/66-study is the first longitudinal study examining 
the association between depressive symptoms and incidence of dementia in LMICs and Latin 
America. Only a few cross-sectional studies have previously reported on the associations 
Associations between depression and incidence of dementia in Latin America 
 
11 
 
between depression and dementia in older people living in LMIC populations [32-34]. The 
findings are in line with previous published meta-analyses conducted in high-income 
populations [7-9]. A report from Alzheimer’s Disease International (ADI) presented pooled 
data from 32 studies (n=62 598, baseline mean age ranged 70-89 years, median follow-up 5 
years) and showed that depression doubled the risk of developing dementia [6].  
 
The prevalence of cognitive and affective disorders differ between countries and cultures 
around world. Today, the majority of people with dementia lives in LMICs [26] and it is 
estimated that these countries will see the most rapid increase of dementia in the following 
decades [1]. In addition, depression is a common health problem in late-life [3] and population-
based studies in LMICs and Latin America report that up to one third of older adults can be 
affected by depressive symptomatology [4, 5]. The incidence of depression have however 
considerable variations both in Latin America populations [4] and in other parts of the world 
[35], most likely as a consequence of cultural, demographic and socio-economic factors. This 
high variation may also be due to methodological issues and differences in evaluation of 
symptoms. In the 10/66-study, every effort was made to ensure a conceptual equivalence of all 
interview questionnaires´ items. The research teams underwent substantial training to ensure a 
consistent approach in the administration of assessments across different cultural settings in 
accordance with manualised standard operational procedures. The variation in prevalence of 
depression between the study sites is therefore unlikely to be the result of measurement errors. 
 
The underlying mechanisms by which depression is associated with dementia in older adults 
are complex and may have several explanations. It remains unclear whether depression itself 
initiates or worsen the trajectory of dementia, or if depression is an early sign of incipient 
dementia. The most prominent biological mechanisms that may link depression to dementia are 
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likely to be the results of shared nervous, [36, 37] vascular, [38] and inflammatory [39] 
pathways. For example, depression increases the activity of the hypothalamic-pituitary-adrenal 
(HPA) axis and thus the levels of glucocorticoid hormones in the brain, which in turn have been 
associated with hippocampus atrophy and memory problems [36]. Depression is also associated 
with dysregulation in the nervous system, e.g. low serotonin and noradrenaline levels in brain, 
which have been related to impaired cognitive function [37]. Another explanation could be that 
depression is associated with prolonged low-grade inflammation that in the long-term may have 
a damaging effects on neurons and brain blood vessels [40].  
 
It is well known that the neurodegenerative processes in the brain often starts many years before 
a person fulfil the diagnostic criteria for dementia [41]. Early neurodegenerative changes in the 
brain may increase the vulnerability to depression and the association between depression and 
incipient dementia can thus reflect a prodromal state of dementia. In our case, 4 years of follow-
up is a relative short period of monitoring, which made it difficult to fully establish the direction 
of the association, e.g. that the depression itself causes changes that lead to dementia. Cognitive 
and physical function due to incipient dementia process may also have impact on the mental 
wellbeing and result in psychiatric symptoms, such as low mood and anxiety [42].   
 
Cognitive symptoms are common in the context of depression and mood symptoms frequently 
accompany cognitive disorders. Several symptoms of depression e.g. concentration problems, 
sleeping problems, agitation, fatigue and lack of appetite, are also common in people with 
dementia, and partly used as diagnostic criteria [19, 22]. Different types of underlying 
neuropathology may thus appear as shared clinical symptomatology. The 10/66-study has 
however no biological measurements, such as magnetic resonance imaging (MRI) or 
cerebrospinal fluid markers (CSF), to identify specific brain pathologies.   
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It can be a challenge for clinicians assessing and treating older patients, with co-morbid 
cognitive and affective symptoms. Studies on psychopharmacology drugs show inconsequent 
results, and antidepressant treatment has been associated with both increased [43] and reduced 
[44] risk of dementia. 
 
Strength and limitations 
The strengths of this study include a large population-based sample in LMICs, a longitudinal 
study design, face-to-face interviews, and a systematic data collection with identical 
standardised protocols. Assessment of depression was done by a validated and structured 
interview that was designed specifically for these older populations, which helped in comparing 
results across countries using a standardized method. Some methodological issues need 
however to be considered. First, lack of data on sub-types of dementia, e.g. Alzheimer’s disease 
or vascular dementia, limit our understanding of this association in respect to underlying 
neurobiological processes. Second, we have no information about the time of onset of 
depression. It is possible that the association between depression and dementia may be affected 
by the duration of depression, the numbers of episodes, and the type of treatment received. 
Third, no information was available on psychopharmacological treatment, i.e. anti-depressant 
medication or psychological intervention, which can influence the association between 
depression and dementia. Fourth, some residual confounding factors which were not measured 
could still exist. For example, other physical and mental health conditions, and life-style factors 
such as e.g. smoking, alcohol, and stress. Fifth, in people who deceased between baseline and 
follow-up, information on dementia was assessed using a post-mortem informant interview, 
which may have lower validation than the standardised diagnostically processes from the 
examinations. The same approach have however been used in several previous 10/66 studies 
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[45, 46], and a sensitivity analysis, which did not include the post-mortem information did not 
show any major difference in regards to the findings. Sixth, cumulative attrition is a problem in 
long follow-up studies and the participation in the follow-up examination may thus be healthier 
and have less dementia than the general population. Finally, people with mild cognitive 
impairment (MCI) were not excluded from baseline. This could potentially have affected the 
results of the study, as pathological changes in the brain may have already started occurring in 
this group of participants. 
 
Conclusion and implications 
Our study found that depression was associated with incidence of dementia over a 4-year 
follow-up period, even though variation was found across countries. Further research need to 
explore more about this variance, to understand whether contextual factors may explain these 
differences. For clinicians, this study strengthen the evidence supporting the importance of a 
cognitive examination of older people who present with depressive symptoms. 
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Table 1. Sociodemographic characteristics of the sample 
 Cuba Dominican 
Republic 
Peru Venezuela Mexico Puerto Rico Across centres 
Number of participants at risk, n 2517 1769 1767 1820 1823 1776 11472 
Median follow-up to outcome, y (IQR) 4.1 (3.4-5.0) 5.0 (3.3-5.1) 3.0 (2.5-3.7) 4.2 (3.9-4.7) 3.0 (2.9-3.1) 4.3 (3.7-4.7) 3.8 (2.9-4.7) 
Mean age at baseline (SD) 74.4 (6.6) 74.5 (7.1) 74.2 (6.9) 72.0 (6.4) 73.6 (6.3) 75.4 (6.8) 74.0 (6.8) 
Females, n (%) 1628 (64.7) 1156 (65.4) 1073 (60.7) 1150 (63.2) 1144 (62.8) 1190 (67.3) 7341 (64.0) 
Prevalence baseline depression, n (%)        
ICD-10 depressive episode 118 (4.7) 221 (12.5) 86 (4.9) 84 (4.6) 73 (4.0) 37 (2.0) 619 (5.4) 
Sub-syndromal depression  455 (18.1) 417(23.6) 399 (22.6) 421 (23.1) 424 (23.3) 253 (14.3) 2369 (20.6) 
Any depression 573 (22.8) 638 (36.1) 485 (27.5) 505 (27.7) 497 (27.3) 290 (16.3) 2988 (26.0) 
Education level, n (%)        
None 54 (2.1) 315 (17.9) 103 (5.9) 133 (7.4) 461 (25.3) 47 (2.6) 1113 (9.7) 
Some 522 (20.8) 917 (52.0) 212 (12.1) 408 (22.6) 802 (44.0) 316 (17.8) 3177 (27.8) 
Completed primary 829 (33.0) 338 (19.2) 654 (37.2) 913 (50.5) 337 (18.5) 358 (20.2) 3429 (30.0) 
Completed secondary 661 (26.3) 126 (7.1) 486 (27.7) 262 (14.5) 117 (6.4) 663 (37.2) 2315 (20.3) 
Tertiary (college) 446 (17.5) 66 (3.7) 301 (17.1) 92 (5.1) 104 (5.7) 385 (21.7) 1394 (12.2) 
Stroke, n (%) 158 (6.3) 118 (6.7) 106 (6.0) 111 (6.1) 120 (6.6) 124 (7.6) 737 (6.5) 
Diabetes, n (%) 466 (18.6) 253 (14.3) 158 (9.0) 283 (15.6)   398 (21.8) 569 (32.2) 2127 (18.6) 
Status at follow up        
      Interviewed, n (%) 1851 (73.5) 1071 (60.4) 1214 (68.7) 1192 (65.5) 1355 (74.3) 1174 (66.5) 7857 68.5) 
      Deceased, n (%)  449 (17.8)  370 (20.9) 109 (6.2) 161 (8.9) 166 (9.1) 200 (11.3) 1455 (12.7) 
      Lost, n (%) 217 (8.6) 328 (18.5) 444 (25.1) 467 (25.7) 302 (16.6) 402 (22.7) 2160 (18.8) 
Outcome        
      Censored, n (%) 1681 (73.1) 953 (66.1) 1145 (86.6) 1057 (78.1) 1234 (81.1) 1051 (76.5) 7121 (76.5) 
      Incident dementia, n (%) 182 (7.9) 165 (11.4) 77 (5.8) 155 (11.5) 130 (8.6) 153 (11.1) 862 (9.3) 
      Competing risk, n (%) 437 (19.0) 323 (22.4) 101 (7.6) 141 (10.4) 157 (10.3) 170 (12.4) 1329 (14.3) 
IQR= Interquartile range 
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Table 2. Sub-hazard ratios for incident dementia in persons with ICD-10 depressive episode at baseline   
 Unadjusted  
sHR (95% CI) a 
 Model 2 
sHR (95% CI) a 
 Model 3  
sHR (95% CI) a 
 
Cuba 2.53 (1.58-4.07)  2.45 (1.50-4.01)  2.48 (1.52-4.06)  
Dominican Republic 1.18 (0.75-1.85)  1.00 (0.62-1.06)  1.01 (0.62-1.62)  
Peru 1.71 (0.74-3.96)  1.43 (0.64-3.22)  1.39 (0.61-3.19)  
Venezuela 2.84 (1.62-4.97)  2.53 (1.40-4.59)  2.12 (1.16-3.87)  
Mexico 1.82 (0.87-3.81)  1.79 (0.85-3.76)  1.82 (0.87-3.82)  
Puerto Rico 0.76 (0.18-3.20)  0.87 (0.21-3.68)  0.81 (0.19-3.48)  
  I2  I2  I2 
Pooled 1.85 (1.44-2.37) 45.9% 1.38 (1.12-1.68) 68.1% 1.63 (1.26-2.11) 40.9% 
Competing risk models presented using sub-hazard ratios (sHR) and 95% confidence interval (CI). I2 = Higgins I2 
Model 1: unadjusted, Model 2: adjusted for age, gender and education level, and Model 3: adjusted for age, gender, education level, stroke, and diabetes  
a people with no depression were used as the reference group  
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Table 3. Sub-hazard ratios for incident dementia in people with sub-syndromal depression at baseline   
 Unadjusted  
sHR (95% CI) a 
 Model 2  
sHR (95% CI) a 
 Model 3  
sHR (95% CI) a 
 
Cuba 0.98 (0.66-1.45)  0.89 (0.59-1.33)  0.88 (0.59-1.32)  
Dominican Republic 1.21 (0.85-1.72)  1.11 (0.78-1.57)  1.10 (0.77-1.56)  
Peru 0.99 (0.57-1.71)  0.82 (0.46-1.46)  0.82 (0.47-1.46)  
Venezuela 2.10 (1.50-2.95)  2.22 (1.56-3.14)  2.13 (1.50-3.03)  
Mexico 1.41 (0.96-2.05)  1.38 (0.94-2.01)  1.37 (0.93-2.02)  
Puerto Rico 1.43 (0.96-2.14)  1.47 (0.97-2.22)  1.38 (0.90-2.12)  
  I2  I2  I2 
Pooled 1.37 (1.17-1.60) 53.7% 1.32 (1.12-1.55) 68.7% 1.28 (1.09-1.51) 66.0% 
Competing risk models presented using sub-hazard ratios (sHR) and 95% confidence interval (CI). I2 = Higgins I2 
Model 1: unadjusted, Model 2: adjusted for age, gender and education level, and Model 3: adjusted for age, gender, education level, stroke, and diabetes  
a people with no depression were used as the reference group  
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Supplementary Table 1. Sub-hazard ratios for incident dementia, in people with depressive episode at baseline. Participants who died before the follow-up examination were considered as 
deceased (the competing risk) in the analyses, and the results of the verbal autopsies were not taken into consideration.  
 
  Unadjusted  
sHR (95% CI) a 
 Model 2  
sHR (95% CI) a 
 Model 3  
sHR (95% CI) a 
 
Cuba ICD-10 depression 
Sub-syndromal depression 
2.08 (1.22-3.52) 
1.00 (0.68-1.49)  
 1.92 (1.11-3.33) 
0.90 (0.60-1.36)  
 1.95 (1.12-3.36) 
0.89 (0.59-1.35) 
 
Dominican Republic ICD-10 depression 
Sub-syndromal depression 
1.12 (0.64-1.97) 
1.46 (0.98-2.18) 
 0.92 (0.51-1.67) 
1.27 (0.86-1.89) 
 0.92 (0.50-1.68) 
1.25 (0.84-1.86)  
 
Peru ICD-10 depression 
Sub-syndromal depression 
1.60 (0.64-4.01) 
1.05 (0.60-1.86) 
 1.33 (0.55-3.19) 
0.93 (0.51-1.66) 
 1.28 (0.52-3.14) 
0.93 (0.52-1.66) 
 
Venezuela ICD-10 depression 
Sub-syndromal depression 
2.44 (1.30-4.59) 
2.04 (1.42-2.93)  
 2.07 (1.02-4.19) 
2.11 (1.46-3.05)  
 1.84 (0.89-3.82) 
2.07 (1.42-3.00)  
 
Mexico ICD-10 depression 
Sub-syndromal depression 
1.96 (0.93-4.10) 
1.39 (0.94-2.07)  
 1.93 (0.22-4.04) 
1.37 (0.92-2.02)  
 1.97 (0.94-4.11)  
1.36 (0.91-2.03)  
 
Puerto Rico ICD-10 depression 
Sub-syndromal depression 
0.99 (0.24-4.16) 
1.55 (1.00-2.40) 
 1.11 (0.27-4.64) 
1.56 (1.00-2.45) 
 1.05 (0.25-4.47) 
1.50 (0.96-2.35)  
 
   I2  I2  I2 
Pooled ICD-10 depression 
Sub-syndromal depression 
1.73 (1.31-2.29) 
1.42 (1.20-1.68) 
0% 
39% 
1.48 (1.09-2.02) 
1.40 (1.18-1.66) 
0% 
48.7% 
1.51 (1.12-2.02) 
1.33 (1.12-1.59) 
0% 
53.9 
Competing risk models presented using sub-hazard ratio (sHR) and 95% confidence interval (CI). I2 = Higgins I2 
Model 1: unadjusted, Model 2: adjusted for age, gender and education level, and Model 3: adjusted for age, gender, education level, stroke, and diabetes  
a people with no depression were used as the reference group  
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Supplementary Table 2. Hazard ratios for incident dementia in people with ICD-depression and sub-syndromal depression, using Cox regression analyses.  
 
  Unadjusted  
HR (95% CI) a 
 Model 2  
HR (95% CI) a 
 Model 3  
HR (95% CI) a 
 
Cuba ICD-10 depression 
Sub-syndromal depression 
2.57 (1.59-4.17) 
1.02 (0.69-1.51) 
 2.58 (1.58-4.20) 
0.95 (0.64-1.42) 
 2.55 (1.56-4.18) 
0.93 (0.62-1.39) 
 
Dominican Republic ICD-10 depression 
Sub-syndromal depression 
1.29 (0.82-2.04) 
1.23 (0.87-1.75) 
 1.14 (0.72-1.81) 
1.12 (0.78-1.61) 
 1.15 (0.72-1.82) 
1.11 (0.78-1.61) 
 
Peru ICD-10 depression 
Sub-syndromal depression 
1.84 (0.79-4.27) 
0.99 (0.57-1.70) 
 1.40 (0.60-3.26) 
0.82 (0.47-1.44) 
 1.34 (0.57-3.15) 
0.82 (0.47-1.44) 
 
Venezuela ICD-10 depression 
Sub-syndromal depression 
3.12 (1.77-4.49) 
2.14 (1.52-3.00) 
 3.21 (1.79-5.77) 
2.38 (1.69-3.36) 
 2.63 (1.41-4.92) 
2.29 (1.61-3.24) 
 
Mexico ICD-10 depression 
Sub-syndromal depression 
1.81 (0.88-3.75) 
1.42 (0.97-2.07) 
 1.80 (0.87-3.72) 
1.38 (0.94-2.02) 
 1.83 (0.88-3.80) 
1.38 (0.94-2.02) 
 
Puerto Rico ICD-10 depression 
Sub-syndromal depression 
0.79 (0.20-3.21) 
1.40 (0.94-2.10) 
 0.85 (0.21-3.45) 
1.44 (0.96-2.17) 
 0.76 (0.19-3.13) 
1.36 (0.89-2.04) 
 
   I2  I2  I2 
Pooled ICD-10 depression 
Sub-syndromal depression 
2.03 (1.60-2.57) 
1.38 (1.18-1.62) 
49.6% 
52.6% 
1.84 (1.43-2.37) 
1.35 (1.15-1.59) 
54.7% 
71.6% 
1.74 (1.35-2.25) 
1.32 (1.12-1.55) 
43.0% 
69.1% 
Cox regressions presented using by hazard ratios (HR) and 95% confidence interval (CI). I2 = Higgins I2 
Model 1: unadjusted, Model 2: adjusted for age, gender and education level, and Model 3: adjusted for age, gender, education level, stroke, and diabetes  
a people with no depression were used as the reference group  
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Figure 1. Flow-chart of participants at baseline and follow-up 
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